• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail

  • Print
  • Share
  • E-mail
Pediatric Labeling Date:  02/23/2007
Trade Name:  Vyvanse Capsules
Generic Name or Proper Name (*):  lisdexamfetamine
Indications Studied:  Treatment of ADHD in children 6 to 12 years of age
Label Changes Summary:  * Effectiveness established in two studies of patients 6-12 years of age * Long-term effectiveness of more than 4 weeks has not been established * Studies waived in children 0-5 years of age and deferred in children 13-17 years of age * New active ingredient
Product Labeling:  Labeling  Opens a new window
Sponsor:  New River
Therapeutic Category:  CNS Stimulant